🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Response and Material Elimination

Based on the social media company, the platform has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or injecting at residence.

After moments of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Details and Costs

Within these communities, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious health risks”.